Acute Respiratory Failure Clinical Trial
Official title:
Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial
The purpose of this study is to determine whether, as compared with the Venturi mask, a nasal, high-flow oxygenation device (Optiflow) may reduce the extubation failure rate in patients needing oxygen therapy after extubation.
This study compares the effects of two devices for oxygen therapy, the nasal, high-flow
(Optiflow, intervention) and the Venturi mask (control), on the outcome of extubation.
Available data suggest that Optiflow can improve oxygenation and patient's comfort in
critically ill patients after extubation. The study hypothesis is that Optiflow may reduce
the extubation failure rate in these patients.
In the intervention group, patients fulfilling inclusion criteria and not presenting any of
the exclusion criteria will receive high-flow oxygen through nasal cannula (Optiflow, Fisher
& Paykel Healthcare Ltd., New Zealand) after extubation. The oxygen concentration (FiO2) will
be set to reach an oxygenation target similar to control patients (see below), while the gas
flow rate will be set at 50 L/min.
In the control group, patients fulfilling inclusion criteria and not presenting any of the
exclusion criteria will receive oxygen through a standard Venturi mask after extubation. The
FiO2 will be set to obtain a arterial oxygen saturation (SpO2) between 92% and 98% (or
between 88% and 95% in hypercapnic patients). Further FiO2 modifications will be performed by
the attending physicians to meet the oxygenation target.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
| Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
| Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
| Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
| Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
| Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
| Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
| Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
| Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
| Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
| Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
| Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
| Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
| Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
| Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
| Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
| Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
| Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
| Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |